Table 1.
Study | IS | LAA | CE | SVD | Controls |
---|---|---|---|---|---|
ASGC | 1,071 | 375 | 226 | 287 | 1,212 |
WTCCC2-Munich | 1,140 | 338 | 322 | 104 | 775† |
WTCCC2-UK | 2,350 | 494 | 450 | 471 | 5,107 |
| |||||
Total | 4,561 | 1,207 | 998 | 862 | 7,094 |
LAA, large artery atherosclerosis; CE, cardioembolism; SVD, small vessel disease.
WTCCC2-Munich controls were selected from the German KORA study, which also contributed to kidney trait meta-analyses.